3 ms·

I can't seem to find the name of nature of the drug in question, does anyone know it? I ask because full CB1 agonists are already known to be problematic, but n

I can't seem to find the name of nature of the drug in question, does anyone know it? I ask because full CB1 agonists are already known to be problematic, but none of the articles mention anything other than endocannabinoid

TacticalMalice 11y ago
There's speculation the structural family was disclosed in Bial's patent application http://www.freepatentsonline.com/20150174103.pdf http://www.freepatentsonline.com/20150174103.pdf